BioLineRx Ltd.
(NASDAQ : BLRX)

( )
BLRX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc. 1.71%30.2614.1%$178.05m
AMRNAmarin Corp. Plc -0.75%19.911.7%$164.99m
AXSMAxsome Therapeutics, Inc. -2.31%90.341.9%$138.85m
SAVACassava Sciences, Inc. -4.40%8.250.0%$90.26m
ARQLArQule, Inc. 0.15%20.000.6%$80.30m
BHCBausch Health Cos., Inc. 1.71%30.260.0%$72.67m
SAGESAGE Therapeutics, Inc. 3.12%76.408.6%$71.43m
JAZZJazz Pharmaceuticals Plc -0.36%151.052.3%$68.74m
GWPHGW Pharmaceuticals Plc -0.13%118.976.2%$67.44m
ICPTIntercept Pharmaceuticals, Inc. -3.76%106.1116.9%$60.73m
PRGOPerrigo Co. Plc -0.82%59.026.8%$58.59m
HZNPHorizon Therapeutics Plc 0.29%38.406.6%$58.11m
ICLRICON plc 0.38%175.784.2%$42.92m
ENDPEndo International Plc -2.27%6.048.8%$42.08m
CTLTCatalent, Inc. -1.03%60.842.4%$38.13m

Company Profile

BioLineRx Ltd. is a clinical-stage biopharmaceutical company, which includes indentifying, in-licensing, and developing therapeutic candidates. Its in-licenses novel compounds, primarily from academic institutions and biotech companies based in Israel, and develops them through pre-clinical and clinical stages, and then partners with pharmaceutical companies clinical development and commercialization. The company was founded in April 2003 and is headquartered in Modi'in, Israel.